Selskabets formål er udvikling, produktion af produkter til medicinalindustrien samt dertil ligeartet virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 13.3 mio. | -1.9 mio. | 4.9 mio. | -1.5 mio. | 18 | |
CVR: 34724938
Secondary names: SOLUORAL PHARMA ApS, SOLORAL PHARMA ApS, Solural Pharma ApS
Previous names: SOLURAL PHARMA ApS
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Helle Kirstein Erichsen joined as director
Ann Vivian Fullerton left as director
Companies in the same industry and area
companydata.dk